国泰海通证券股份有限公司 关于华虹半导体有限公司 与上海复旦微电子集团股份有限公司发生日常关联交易的核 查意见 国泰海通证券股份有限公司（以下简称"保荐机构"）作为华虹半导体有限公 司（以下简称"华虹公司"或"公司"）首次公开发行人民币普通股（A股）股票并 在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交 易所科创板股票上市规则》《上海证券交易所上市公司自律监管指引第11号——持 续督导》《上海证券交易所科创板上市公司自律监管指引第1号——规范运作》等有 关规定，对华虹公司与上海复旦微电子集团股份有限公司（以下简称"复旦微电"） 发生日常关联交易事项进行了审慎核查，具体情况如下： 一、日常关联交易基本情况 （一）日常关联交易履行的审议程序 公司董事会于2025年8月28日就与复旦微电发生日常关联交易相关事宜作出决议， 同意公司及其合并报表范围内公司因生产经营需要，在不超过相应额度的范围内与 关联方复旦微电开展相关交易。根据《上海证券交易所科创板股票上市规则》（以 下简称"《科创板上市规则》"）的规定，公司全体独立董事同意通过上述议案。 根据《科创板上市规则》及《华虹半导体有限公司之组织 ...

国泰海通证券股份有限公司 关于上海硅产业集团股份有限公司 部分募投项目延期的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐人"）作为上海硅 产业集团股份有限公司（以下简称"沪硅产业"、"公司"或"发行人"）2021 年度向 特定对象发行股票的保荐人，根据《证券发行上市保荐业务管理办法》《上市公 司募集资金监管规则》《上海证券交易所科创板上市公司自律监管指引第 1 号— —规范运作》《上海证券交易所科创板股票上市规则》等有关法律法规和规范性 文件的要求，对沪硅产业部分募投项目延期的事项进行了核查，核查情况如下： 一、募集资金基本情况 二、募集资金投资项目情况 根据公司《上海硅产业集团股份有限公司 2021 年度向特定对象发行 A 股股 票募集说明书》披露，本次募集资金主要用于"集成电路制造用 300mm 高端硅 片研发与先进制造项目"、"300mm 高端硅基材料研发中试项目"和"补充流动 资金"，具体使用情况如下： | | | | --- | --- | | . K | . | | "共自以火心 | | --- | 根据中国证券监督管理委员会核发的《关于同意上海硅产业集团股份有限公 司向特定对 ...

Core Viewpoint - The report outlines the continuous supervision and guidance provided by Guotai Junan Securities for Huahai Qingke Co., Ltd. during the first half of 2025, emphasizing the company's compliance with regulations and its operational performance [2][9]. Summary by Sections Continuous Supervision Work - The sponsor has established a continuous supervision system to ensure the company adheres to regulatory obligations, including information disclosure and operational compliance [2][3]. - The sponsor has assisted the company in developing internal systems and decision-making processes to meet legal and regulatory requirements [3][4]. - The company has maintained transparency in its information disclosure, ensuring it is accurate, complete, and timely [3][4]. Financial Performance - For the first half of 2025, the company reported a revenue of approximately RMB 1.95 billion, a year-on-year increase of 30.28% [17]. - The total profit reached approximately RMB 549.78 million, reflecting an 11.66% increase compared to the previous year [17]. - The net profit attributable to shareholders was approximately RMB 505 million, marking a 16.82% increase [17]. R&D and Innovation - The company has a strong focus on R&D, with R&D expenses accounting for 12.63% of revenue, an increase from 11.72% in the previous year [17][22]. - The company has developed a robust R&D team of 722 members, representing 31.99% of its total workforce [19][20]. - The company has obtained 500 patents and 39 software copyrights, showcasing its commitment to innovation [19][20]. Risk Management - The company faces risks related to core competitiveness, including potential talent loss and technological advancements in the semiconductor equipment industry [9][10]. - The company has established a quality management system to ensure product quality and customer satisfaction [20][21]. - The company is exposed to financial risks, particularly concerning accounts receivable and customer concentration [12][13]. Use of Raised Funds - The company raised a total of RMB 364.43 million through its IPO, with a net amount of RMB 348.99 million after deducting issuance costs [2][23]. - As of June 30, 2025, the company has utilized RMB 111.58 million of the raised funds for designated projects [23]. - The company has ensured compliance with regulations regarding the management and use of raised funds [23].

市规则》 等有关法律法规和规范性文件的要求，对中微公司使用自有资金支付募投项目所 需资金并以募集资金等额置换事项进行了审慎核查，具体情况如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到账情况 经上海证券交易所审核同意，并根据中国证券监督管理委员会于 2021 年 3 月 3 日出具证监许可[2021]645 号文《关于同意中微半导体设备（上海）股份有 限公司向特定对象发行股票注册的批复》，公司向特定对象发行 80,229,335 股人 民币普通股 A 股股票。截至 2021 年 6 月 22 日止，公司完成了人民币普通股 A 股 80,229,335 股的发行，每股发行价格为人民币 102.29 元，股款以人民币缴足， 合计人民币 820,665.87 万元，扣除承销及保荐费用共计人民币 8,206.66 万元（不 含增值税）后，实际收到募集资金计人民币 812,459.21 万元，再扣除其他发行费 用人民币合计 642.96 万元（不含增值税）后，实际募集资金净额为人民币 到位，业经普华永道中天会计师事务所（特殊普通合伙）予以验证并出具了普华 永道中天验字（2021）第 0638 号验资报告。 ...

王 胜 ??????????????雾??仍??? 杨 ?????????????? ??????O????????????????? ?????????????π????????ā????????、????? ????????????π????、?ā??????ā?徐???????????????? 、??к??2023 ???????????????????????????? к?????ъ?????? ?к?????、???к???? ?к????? ?、 ??к????????? 1 ?üü????????????????? ????????、??? 2025 ?????????有?仍??亩???y由 ???????o???π? a????????????? ?a??????????????? ????? 2025 ? 4 ? 24 ??????????????????????? ???a????????????享????? 2025 ??????????????????? ??壳? 2025 ???????????仍ㅠ?? 11,250.00 s?????????????????????? ???? ...

Group 1 - The articles discuss ongoing developments in the agricultural sector, particularly focusing on land usage and productivity metrics [1][2] - There is a mention of specific acreage figures, indicating that certain areas remain underutilized despite potential for growth [1][2] - The timeline for projected changes in land use and productivity extends to 2025, highlighting future expectations for the industry [1][2] Group 2 - The articles emphasize the importance of regulatory reviews and approvals in the agricultural sector, which may impact land development and usage [1][2] - There are references to ongoing assessments of land productivity, suggesting that current practices may not be fully optimized [1][2] - The discussion includes potential shifts in land management strategies as the industry looks towards future sustainability and efficiency [1][2]

国泰海通证券股份有限公司 关于上海益诺思生物技术股份有限公司 使用部分暂时闲置募集资金进行现金管理的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐人"）作为上 海益诺思生物技术股份有限公司（以下简称"益诺思"、"公司"或"发行人"） 首次公开发行股票并在科创板上市持续督导的保荐机构，根据《证券发行上市保 荐业务管理办法》 《上市公司募集资金监管规则》 《上海证券交易所科创板上市公 司自律监管规则适用指引第 1 号——规范运作》等有关法律法规和规范性文件的 要求，就益诺思使用部分暂时闲置募集资金进行现金管理的事项进行了审慎核查， 并发表如下核查意见: 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意上海益诺思生物技术股份有 限公司首次公开发行股票注册的批复》 （证监许可〔2024〕762 号），公司首次公 开发行人民币普通股（A 股）3,524.4904 万股（以下简称"本次发行"），每股发 行价格为人民币 19.06 元，本次发行募集资金总额 67,176.79 万元，扣除发行费 用后，募集资金净额为 60,964.49 万元。上述募集资金已到位，经立信会计师事 务所（特殊普 ...

Core Viewpoint - The company intends to utilize part of its temporarily idle raised funds for cash management, ensuring that it does not affect the normal operation of fundraising investment projects and guarantees the safety of funds [1][4][8]. Fundraising Basic Information - The company raised a total of RMB 3,255,615,848.10 from its initial public offering of 32,984,963 shares at a price of RMB 9.87 per share, with all funds received and verified by an accounting firm [1][2]. Cash Management Purpose - The cash management aims to improve the efficiency of fund usage, increase cash asset returns, and protect shareholder interests while ensuring that fundraising investment projects are not impacted [4][5]. Cash Management Products - The company plans to invest in high-safety, liquid, principal-protected products, including but not limited to time deposits, large certificates of deposit, and notice deposits [4][5]. Investment Limit and Duration - The company intends to use up to RMB 130,000 million of temporarily idle funds for cash management, with a validity period of 12 months from the board's approval [4][5]. Implementation Method - The board authorizes the management to make investment decisions and sign relevant legal documents, with the finance management center responsible for organizing the implementation [4][5]. Information Disclosure - The company will fulfill its information disclosure obligations in accordance with relevant regulations and guidelines [5][8]. Cash Management Income Distribution - The income from cash management will be used to supplement any shortfall in the investment amounts of fundraising projects, and the funds will be returned to the fundraising special account upon maturity [5][8]. Impact on Company Operations - The cash management will not affect the normal operation of fundraising investment projects or the company's main business, and it is expected to enhance overall performance and shareholder returns [5][8]. Review Procedures - The board and supervisory board have approved the cash management proposal, confirming that it aligns with regulatory requirements and does not harm the interests of the company or its shareholders [7][8]. Sponsor's Verification Opinion - The sponsor has verified that the cash management plan complies with relevant regulations and will enhance fund usage efficiency without altering the intended use of the raised funds [8].

Core Viewpoint - The company is utilizing excess raised funds to replace previously invested self-raised funds for ongoing projects, ensuring compliance with regulatory requirements and maintaining the integrity of fundraising purposes [1][5][7]. Fundraising Overview - The company was approved to issue 40 million shares at a price of RMB 28.82 per share, raising a total of RMB 1,152.8 million, with a net amount of RMB 1,049.66 million after deducting issuance costs. The excess funds raised amounted to RMB 341.66 million [1][2]. Investment Project Details - The total investment for the planned projects is RMB 1,009.62 million, with adjusted investment amounts for specific projects, including the rehabilitation equipment research and exhibition center, which saw its total investment increase from RMB 146.73 million to RMB 228.73 million [2][3]. Use of Excess Funds - The company decided to use RMB 79.12 million of the excess funds for the construction of the rehabilitation medical device industrial park, specifically for the research center and related facilities. This decision was approved in the board meeting held on April 23, 2025 [3][4]. Replacement of Self-raised Funds - The company plans to replace RMB 12.91 million of self-raised funds that were previously invested in the rehabilitation medical device industrial park with the excess funds. This replacement was approved in the board meeting on August 27, 2025 [4][5]. Compliance and Verification - The supervisory board and the accounting firm confirmed that the use of excess funds complies with relevant regulations and does not affect the normal implementation of investment projects. The replacement of funds was verified by the accounting firm, ensuring adherence to regulatory standards [5][7][8].

国泰海通证券股份有限公司 关于 科大国盾量子技术股份有限公司 收购报告书 之 财务顾问 二〇二五年八月 国泰海通证券股份有限公司（以下简称"国泰海通"、"本财务顾问"） 接受委托，担任中电信量子信息科技集团有限公司（以下简称"中电信量子集 团"、"收购人"）及其一致行动人收购科大国盾量子技术股份有限公司（以 下简称"国盾量子"、"上市公司"、"公司"）的财务顾问，依照《上市公 司收购管理办法》（以下简称"《收购办法》"）第六十九条、第七十一条、 《上市公司并购重组财务顾问业务管理办法》第三十一条等有关规定，持续督 导期从国盾量子公告收购报告书至收购完成后的 12 个月止（即从 2024 年 3 月 半年度报告及日常沟通，国泰海通出具了 2025 年二季度（从 2025 年 4 月 1 日 至 2025 年 6 月 30 日，以下简称"本持续督导期"）的持续督导意见（以下简 称"本意见"）。本意见所依据的文件、书面资料等由收购人及其一致行动人 与国盾量子提供，收购人及其一致行动人与国盾量子保证对其真实性、准确性 和完整性承担全部及连带责任。本财务顾问对所发表意见的真实性、准确性和 完整性负责。 释义 | | | ...